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Background: The focus of this study was to evaluate the antimicrobial, mechanical properties and biocompatibility 
of glass ionomer (GICs) modified by Chlorhexidine (CHX). 
Material and Methods: For biocompatibility, 105 male Wistar rats were used, divided into 7 groups (n=15): Group 
C (Control,Polyethylene), Groups M, M10, M18, and Groups RL, RL10, RL18 (M-Meron and RL-Riva Luting: 
conventional, and modified with 10%, and 18% CHX, respectively). The tissues were analyzed under optical mi-
croscope for different cellular events and time intervals. Antibacterial effect and Shear Bond Strength Test (SBST) 
were also analyzed. Biocompatibility was analyzed by the Kruskal-Wallis and Dunn tests; SBST one-way ANOVA 
and Tukey test (P<0.05). For the antibacterial effect, the Kruskal-Wallis and Friedman, followed by Dunn (P<0.05) 
tests were used. 
Results: Morphological study of the tissues showed inflammatory infiltrate with significant differences between 
Groups C and RL18, in the time intervals of 7(P=0.013) and 15(P=0.032) days. The antimicrobial effects of the 
cements was shown to be CHX concentration-dependent (P=0.001). The SBST showed no significant difference 
between the Groups of Meron cement (P=0.385), however, there was difference between Group RL and Groups 
RL10 and RL18 (P=0.001). 
Conclusions: The addition of CHX did not negatively influence the SBST. Meron-CHX-10% was the most biocom-
patible, and Riva-CHX-18% had more influence on the inflammatory process and presented slower tissue repair.
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Introduction
Orthodontic bands provide favorable conditions for the 
colonization of microorganisms (1). Glass ionomer ce-
ment(GIC) has important clinical properties such as 
fluoride release and adhesion to the dental structure (2), 
however, it does not have great antibacterial potential (1).
Antibacterial agents have been investigated so that when 
they are associated with the composition of GICs, they 
would be able to prevent demineralization of the enamel 
adjacent to orthodontic bands, result of bacterial colo-
nization (3) and biofilm growth (4). Chlorhexidine di-
gluconate (CHX) has been demonstrated to be efficient 
against bacterial species found in the oral cavity (5). 
Authors have demonstrated that CHX in high concen-
trations could be toxic to the tissues (5). Added to this, 
GICs (6) may have cytotoxic effects resulting from its 
metallic components (7) that cause damage to gingival 
tissues (8).
Various attempts have been made to develop dental 
materials with antibacterial effect by means of adding 
CHX (9). However, the incorporation of CHX frequent-
ly resulted in changes in the mechanical and biological 
properties of materials, which could affects their clinical 
performance and tissue compatibility (1,9). Thus, the 
focus of this study was to analyze the antimicrobial, me-
chanical properties and biocompatibility of GICs with 
the addition of CHX.
Material and Methods
-Experimental groups and animal model
Two GICs were used for cementation and contained 
10% tartaric acid, Meron(Voco, Cuxhaven,  Germany, 
Lot:1123187) and Riva Luting Plus (SDI, Victoria, Aus-
tralia, Lot:10880571). Into another 2 solutions, which 
contained 10% or 18% chlorhexidine digluconate, the 
CHX was incorporated into them in drops in the pro-
portion of 1:1 drops of tartaric acid/CHX by using the 
same dosing dropper, and the solutions were afterwards 
spatulated with the cement powder to obtain a solid ma-
terial (10,11). 
The animal experiment was approved by the Ethics 
Committee on Animal Research, Protocol/No.0582017. 
The sample size calculation was based on pilot study. 
For a standard deviation of 2.23 and a minimal inter-
group difference of 5 for the inflammatory infiltrate to be 
detected, a sample of 5 animals was required to provide 
statistical power of 80% with an alpha of 0.05. 
In this study, 105 adult male Wistar rats with a mean 
weight of 250g were used. A total of 7 groups(n=15 rats 
for group) were created, as follows: Groups M, M10, 
M18 (Meron: conventional, and modified with 10% and 
18% CHX respectively), Groups RL, RL10, RL18 (Riva 
Luting: conventional, and modified with 10% and 18% 
CHX respectively), and Group C (Control, Polyethyle-
ne) (1,11) were tested (Fig. 1).
Fig. 1: Flow Diagram of animals used, groups and tests evaluated.
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Initially, the rats were anesthetized with an intraperitoneal 
injection of sodium thiopental (50mg/kg) (Cristália, SP, 
Brazil). Trichotomy was performed in the dorsal region 
of each animal, and for antisepsis, 4% chlorhexidine di-
gluconate was used (12,13). On the midline, equidistant 
from the insertion of the animal’s tale and head, two in-
cisions approximately 8 mm long by 18 mm deep were 
made. Each rat received two tube implants (1.5mm inner 
diameter X 5mm long) made of polyethylene (nontoxic 
Scalp Vein 19G). Previously, the tubes were autoclaved at 
a temperature of 120°C for 20 minutes and then used as 
inoculation vehicles for the tested materials (2).
The experimental materials were handled according to 
the manufacturers’ instructions. The GICs were intro-
duced into the openings at the extremities of the tubes, 
using a syringe (Centrix, Connecticut, USA) supported 
on a glass slide at one extremity and a small glass slide 
at the other to flatten the material. For control Group, 
empty polyethylene tubes were used (2).
After the GICs had set, the tubes were implanted. The 
animals received 0.2 ml intramuscular dose of veteri-
nary pentabiotic (Wyeth, New York, USA), and an in-
jection of sodium dipyrone (0.3ml/100g, Novalgina, SP, 
Brazil). The animals were kept in individual cages under 
adequate conditions with appropriate rations and water 
ad libitum. After time intervals of 7, 15 and 30 days, the 
animals were anesthetized to obtain excisional biopsies, 
afterwards the rats were sacrificed by using a co2 cham-
ber.
-Biocompatibility
The specimens, fixed in 10% formal, were prepared on 
glass slides by means of routine Hematoxylin and Eo-
sin(HE) staining, and afterwards evaluated under an op-
tical microscope Leica DM500® (Leica-Microsystems, 
Wetzlar, Germany), at 100x to 400x magnifications. The 
following histopathological parameters were evaluated: 
inflammatory infiltrate, edema, necrosis, granulation 
tissue, multinuclear giant cells, young fibroblasts and 
collagen fibers, and were awarded points according to 
the following scores:1–absent (when absent in the tis-
sue); 2–scarce (when scarcely present, or in very small 
groups), 3–moderate (when densely present, or in some 
groups) and 4–intense (when found in the entire field, or 
present in large numbers). For each sample of the study, 
five sections representative of the histological condition 
of the tissue adjacent to the implanted materials were 
analyzed (1,11,14). 
The histopathological evaluation was made by a single 
calibrated evaluator (Kappa=0.85). This was a randomi-
zed, triple-blind study; each material was directed to the 
groups I to VII, so that the examiner and statistician had 
no knowledge about the materials. 
-Shear bond strength test-SBST and Adhesive remnant 
index-ARI
For the SBST test, 60(n=10) bovine incisors were used 
(Fig. 1). These were stored in a 0.1% Thymol solution 
until the time they were used for the experiment. The 
teeth were embedded vertical in PVC tubes (25x20mm) 
with acrylic resin(VIPI, SP, Brazil) (15). The vestibular 
surfaces of the crowns were positioned perpendicular 
to the base of the die at an angle of 90º. The vestibular 
surfaces were polished with a rubber cup (KG, Barueri, 
Brazil) and pumice stone(S.S.White,MG,Brazil) at low 
speed for 10 seconds, washed and dried for the same 
length of time (15).
Metal matrices(Morelli, Sorocaba, Brazil), measuring 
4x5mm, were cut and metal brackets (Morelli, Soroca-
ba, Brazil) were welded onto them. The GICs were ma-
nipulated and each matrix was cemented in the center of 
the vestibular surface. After 5 min of initial setting time, 
the samples were stored at 37°C in relative humidity for 
24h (10).
The SBST tests were performed in a universal test ma-
chine with a load cell of 10 Kg (EMIC-DL-200, Paraná, 
Brazil) using a chisel-shaped tip at a speed of 1mm/min. 
The SBST results were obtained in Kgf, transformed 
into N and divided by the bracket base area to provide 
results in MPa. After the test, the vestibular surface of 
each specimen was evaluated under a stereoscopic loupe 
(CarlZeiss, Göttingen, Germany) at 8x magnification, 
with the purpose of quantifying the ARI scores (16).
-Antimicrobial analysis
The antibacterial activity of the GICs was evaluated by 
the agar diffusion test, for which 90 specimens were 
used (n=15) (Fig. 1). The materials were inserted into 
polyethylene molds (6x3mm), left at 25°C for 5 min 
with the mold surfaces covered with a glass plate, and 
then stored at  37°C in 100%  humidity for 60min. The 
samples were individually stored in 2mL of deionized 
water and stored for time intervals of 24h, 30 days and 
90 days, with daily changes of water. 
The bacterial strains of Streptococcus mutans ATCC-
25175 culture stock were cultivated in brain heart infu-
sion (BHI) (DIFCO-Becton, NJ, USA). The dilution of 
10-1, containing 1.2x10-8CFU/ml was used, which was 
determined by means of serial dilution in 0.85% saline 
solution. After incubation at 37°C for 48h, the bacterial 
strain was spread on BHI agar plates and remained there 
at ambient temperature for 30 min. Subsequently, 3 sam-
ples (control, 10% and 18% of CHX) of the same GIC 
were placed on each agar plate in full contact between 
the samples and medium. After this, they were incuba-
ted at 37°C for 48h under microaerophilic conditions, 
and the diameters of the inhibition zones were measured 
with a digital pachymeter (Mitutoyo, Tokyo, Japan) in 
two planes-horizontal and vertical, in the time intervals 
of 24h, 30 days and 90 days.
-Statistical analysis
Distribution of the data was analyzed by the Kolmogo-
rov-Smirnov test (GraphPad-Prism 5.0, San Diego, CA, 
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USA). The results of the cellular events did not present 
normal distribution, therefore, they were submitted to 
the Kruskal-Wallis and Dunn test (P<.05). For SBST and 
ARI, ANOVA one-way and Tukey (P<0.05) tests were 
used. For the antibacterial effect, the Kruskal-Wallis and 
Friedman, followed by Dunn tests were used (P<0.05).
Results
-Morphological study
As regards the results of the morphological study, in the 
initial period, an intense inflammatory infiltrate  was 
shown, particularly in Groups M18 and RL18,  with 
statistically significant difference between the Con-
trol Group and Groups RL18 in the time intervals of 7 
(P=0.013) and 15 (P=0.032) days (Table 1). The inten-
sity of the inflammatory infiltrate was shown to be in-
versely proportional to the experimental time intervals 
(Fig. 2A-E).
Circulatory alterations (edema) and tissue degeneration 
(necrosis) were not expressive and showed no statistical 
difference among the groups evaluated (P>0.05). Granu-




M M10 M18 RL RL10 RL18 C
Inflammatory infiltrate
7 13.75AB 13.75AB 15.00AB 12.50AB 13.75AB 18.75A 10.00B 0.013
15 10.00AB 10.00AB 11.25AB 10.00AB 11.25AB 13.75A 7.50B 0.032
30 10.00 11.25 11.25 10.00 10.00 10.00 7.50 0.119
Edema
7 5.00 5.00 6.25 6.25 5.00 5.00 5.00 0.519
15 5.00 5.00 5.00 5.00 5.00 5.00 5.00 1.000
30 5.00 5.00 5.00 5.00 5.00 5.00 5.00 1.000
Necrosis
7 5.00 5.00 5.00 5.00 5.00 6.25 5.00 0.423
15
30
5.00 5.00 5.00 5.00 5.00 5.00 5.00 1.000
5.00 5.00 5.00 5.00 5.00 5.00 5.00 1.000
Granulation tissue
7 13.75AB 16.25AB 18.75A 13.75AB 16.25AB 16.25AB 11.25B 0.029
15 8.75 10.00 12.50 8.75 10.00 10.00 7.50 0.099
30 6.25 7.50 7.50 7.50 8.75 8.75 6.25 0.696
Multinucleated giant cells
7 7.50AB 10.00AB 12.50A 7.50AB 8.75AB 10.00AB 5.00B 0.013
15 6.25 7.50 7.50 6.25 6.25 6.25 5.00 0.760
30 5.00 5.00 6.25 5.00 6.25 6.25 5.00 0.633
Young fibroblasts
7 13.75AB 12.50AB 10.00AB 12.50AB 11.25AB 8.75A 15.00B 0.031
15 15.00 13.75 13.75 15.00 13.75 12.50 16.25 0.324
30 11.25 13.75 15.00 11.25 11.25 12.50 10.00 0.081
Collagen
7 12.50AB 12.50AB 10.00AB 11.25AB 11.25AB 8.75A 15.00B 0.044
15 16.25 15.00 13.75 16.25 16.25 15.00 18.75 0.107
30 18.75 17.50 17.50 20.00 18.75 18.75 20.00 0.525
Table 1: Mean of the scoresa attributed to the cements, after the time intervals of 7, 15 and 30 days, for the seven conditions 
evaluated.
a For each sample of the study, five representative sections of the histological condition of the tissue were analyzed, when all five 
sections of the tissue showed the same histological condition. Scores: 1, absent (5.00); 2, scarce (10.00); 3, moderate (15.00); and 
4, intense (20.00).
*P indicates nonparametric Kruskal-Wallis test, followed by Dunn’s multiple comparisons test.
A or B Means followed by the same single letter do not express statistically significant difference (P>.05).
AB Means followed by different letters express statistically significant difference (P<.05).
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Fig. 2: A) 7 days after implantation, Group M10:numerous and diminutive congested blood vessels (CV) associated with moderate 
inflammatory infiltrate (MII) (HE, 200X magnification, scale:50µm). Area of polyethylene tube implant (PT). B) 7 days after im-
plantation, Group M18:moderate inflammatory infiltrate (MII), presence of multinucleated giant cells (MGC) close to the foreign 
body (FB), granulation tissue (GT) and congested blood vessels (CV) (HE,100X magnification, scale:100µm). Area of polyethylene 
tube implant (PT). C) 7 days after implantation, Group RL10: Cavity surrounded by moderate inflammatory infiltrate, congested 
blood vessels (CV),reaction of multinucleated giant cells (MGC) and foreign body (FB) (HE, 100X magnification, scale:100µm). 
Area of polyethylene tube implant (PT). D) 7 days after implantation, Group RL18: intense inflammatory infiltrate (III), congested 
blood vessels (CV), multinucleated giant cells (MGC) (HE, 100X magnification, scale: 100µm). Area of polyethylene tube implant 
(PT). E) 7 days after implantation, Group Control: vascularization with congested blood vessels (CV) of various sizes, in the midst 
of proliferation of young fibroblasts (YF) (HE, 400X magnification, scale: 25µm). Area of polyethylene tube implant (PT).
M18 with significant differences in comparison with the 
Control Group (P=0.029), in the time interval of 7 days 
(Fig. 2B,E). Multinucleated giant cells were also shown 
to be more present in Group M18, with statistical diffe-
rence from Control Group in the time interval of 7 days 
(P=0.013) (Table 1) (Fig. 2B).
In the tissue repair events, Group RL18 demonstrated 
a smaller quantity of young fibroblasts (P=0.031) and 
collagen fibers (P=0.044) in the time interval of 7 days 
(Table 1) (Fig. 2D). The quantity of young fibroblasts 
and collagen fibers increased throughout the experimen-
tal time intervals of 15 days (Fig. 3A-E) and 30 days 
(Fig. 4A-E), without significant  difference (P>0.05).
-Antibacterial effect
For the same evaluation time interval the inhibition 
zone measurements were shown to be concentration-de-
pendent; there was significant difference among all the 
groups relative to the difference concentrations of CHX, 
for both the Meron and Riva cements (P=.001) (Table 2). 
All the groups demonstrated a reduction in the antibac-
terial effects from 24h to 30 days, with slight increase 
in the inhibition zones from 30 to 90 days; there was 
significant difference between the time interval of 24h 
and those of 30 and 90 days for Groups M (P=0.001) 
and M10 (P=0.001). But there was significant difference 
between the time intervals of 24h and 30 days for the 
Riva Cement Groups (P=0.001), and for Meron cement, 
only in Group M18 (Table 2).
-SBST and ARI 
The SBST showed no statistically significant difference 
between the Meron Groups of cement (P=0.385) after 
the addition of CHX. For Riva cement, there was signi-
ficant difference between Group RL-control and Groups 
RL10 (10%-CHX) and RL18(18%-CHX) (P=0.001), 
demonstrating an increase in the SBST of the cements 
with the addition of CHX. In the comparison among 
the different brands of GIC for the same concentration 
of solution used, there was significant difference only 
between Groups M-Control and RL-Control (P=0.032)
(Table 3).
The ARI demonstrated that over half of the remnant ce-
ment or all of the remnant cement remained on the tooth 
surface after removing the specimen. The ARI showed 
no statistically significant difference between the Groups 
of Meron cement (P=0.979) and between the Groups of 
Riva cement (P=0.092), after the addition of CHX.
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Fig. 3: A) 15 days after implantation, Group M10: Chronic inflammatory infiltrate (IIC), deposition of collagen fibers (CFD) dis-
posed in parallel bundles, proliferation of young fibroblasts (YF), and multinucleated giant cells (MGC) (HE, 200Xmagnification, 
scale: 50µm). Area of polyethylene tube implant (PT). B) 15 days after implantation, Group M18: Multinucleated giant cells involv-
ing or close to the foreign body (FB) congested blood vessels (CV) (HE ,400Xmagnifications, scale: 25µm). Area of polyethylene 
tube implant(PT). C) 15 days after implantation, Group RL10:Deposition of collagen fibers (CFD) disposed in parallel bundles 
and sometimes dispersed,young fibroblasts (YF),congested blood vessels (CV) (HE, 200X magnification, scale: 50µm). Area of 
polyethylene tube implant (PT). D) 15 days after implantation, Group RL18: Cavity surrounded by chronic inflammatory infiltrate 
(CII), congested blood vessels (CV), Deposition of collagen fibers (CFD) and proliferation of young fibroblasts (YF), presence 
of multinucleated giant cells (MGC) and foreign body (FB) (HE, 100X magnification, scale: 100µm). Area of polyethylene tube 
implant (PT). E) 15 days after implantation, Group Control: Thick layer of collagen fiber deposition (CFD) disposed in parallel 
bundles in the midst of scarce young fibroblasts (YF) congested blood vessels (CV) (HE, 400X magnification, scale: 25µm). Area 
of polyethylene tube implant (PT). 
Discussion 
 In the antimicrobial analysis, a significant increase was 
verified in the measurements of the inhibition haloes of 
the cements that contained CHX, suggesting an increase 
in the antimicrobial effect through the gradual release of 
CHX. These finding corroborated those of other studies 
(3,10), and those that have demonstrated (6,10) that a 
concentration of  10%-CHX was sufficient to provide 
protection against S. mutans, but the increase in this 
concentration increased the antibacterial effect (6), up to 
the maximum concentration allowed of 18% (10). 
Inhibition haloes were significantly larger in the cements 
containing the concentration of CHX-18% (10) in stu-
dies that verified the addition of CHX for 65 days. The 
antimicrobial effect remained present during the expe-
rimental time interval of 90 days, which demonstrated 
that the release of CHX also occurred in the long term, 
and could be important during the entire course of ortho-
dontic treatment. 
The SBST probably is the mechanical test that best repre-
sents the orthodontic clinical situation (10). The addition 
of CHX demonstrated no significant difference in SBST 
for Meron (P=0.385), and Riva cement with the addition 
presented a significant increase (P=0.001). These results 
are in agreement with those of other studies (10,17) that 
demonstrated that the inclusion of CHX in GICs did not 
harm the clinical performance relative to possible distur-
bances such as fracture and/or solubilization, leakages 
and consequent development of caries and periodontal 
disease close to the bands. The IRA demonstrated that 
over half or the entire remnant adhesive remained on the 
tooth surface after removal of the specimen, irrespective 
of the addition of the CHX, proving that CHX did not 
interfere in the bond of GIC to the dental structure.
The focus of the histological analysis was to show the ac-
tion of GICs on tissues by means of a quali-quantitative 
evaluation based on aggression to the vascularized live 
tissue (2). Initial intense inflammatory infiltrate was de-
monstrated by the two cements, particularly in the Groups 
with CHX-18%, however, with significant difference 
only between Riva and the control at 7 (P=0.013) and 15 
(P=0.032) days. Nevertheless, the intensity of the inflam-
matory infiltrate diminished gradually during the expe-
riment, and in the time interval of 30 days it no longer 
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Fig. 4: A) 30 days after implantation, Group M10:  Thin layer of collagen fiber deposition (CFD) disposed in parallel bundles and 
dispersed young fibroblasts (HE, 100X magnification, scale: 100µm). Area of polyethylene tube implant (PT). B) 30 days after 
implantation, Group M18: Deposition of collagen fibers (CFD) sometimes parallel,  sometimes dispersed, proliferation of young 
fibroblasts (YF), Hemorrhagic exudate (HE),congested blood vessels (CV) in  the midst of a light chronic inflammatory infiltrate 
(HE, 200X magnification, scale: 50µm). Area of polyethylene tube implant (PT). C) 30 days after implantation, Group RL10: Cav-
ity surrounded by a thick layer of collagen fiber deposition (CFD), congested blood vessels (CV) (HE, 100X magnification, scale: 
100µm). Area of polyethylene tube implant (PT). D) 30 days after implantation, Group RL18: Cavity surrounded by a collagen fiber 
deposition (CFD), proliferation of young fibroblasts (YF), congested blood vessels (CV) (HE, 200X magnification, scale: 50µm). 
Area of polyethylene tube implant (PT). E) 30 days after implantation, Group Control: Deposition of numerous layers of collagen 
fibers (CFD) disposed in parallel bundles involving the cavity, congested blood vessels (CV) (HE, 400X magnification, scale: 
25µm). Area of polyethylene tube implant (PT).
Period/
Days M M10 M18 P# RL RL10 RL18 P#
1 8.71(0.63)Aa 10.85(0.60)Ba 12.63(0.71)Ca 0.001 9.39(0.50)Aa 10.78(0.69)Ba 12.69(0.56)Ca 0.001
30 5.05(0.31)Ab 6.17(0.21)Bb 7.38(0.36)Cb 0.001 4.56(0.22)Ab 5.09(0.17)Bb 6.48(0.46)Cb 0.001
90 5.21(0.12)Ab 6.61(0.65)Bb 8.12(0.68)Cab 0.001 5.27(0.11)Aab 6.15(0.07)Bab 7.19(0.10)Cab 0.001
*P 0.001 0.001 0.001 ------- 0.001 0.001 0.003   ------
Table 2: Mean and standard deviation (SD), influence of time and concentration of chlorhexidine digluconate on measures of zones of inhibition. 
A or B Means followed by the same single letter do not express statistically significant difference (P>.05).
AB Means followed by different letters express statistically significant difference (P<.05).
#P= Friedman’s non-parametric test, followed by the Dunn multiple-test (in-line, upper case).
*P= Kruskal-Wallis non-parametric test, followed by Dunn’s multiple-comparison test (column, lowercase).
demonstrated significant difference among the groups. 
These findings are in agreement with studies (18,19) that 
showed that CHX is cytotoxic to cells and tissues, and is 
capable of inducing a significant inflammatory reaction 
(6,19) even in lower concentrations than those used in this 
experiment, particularly in the short term.
Human fibroblasts exposed to 0.12% CHX for 30s (20), 
1, 5 and 15min (21) and incubated for a period of reco-
very of 1 day (20) and 7 days (21) respectively, showed 
no significant cellular recovery, which reduced prolife-
ration by over 70% (21). Although the cytotoxicity of 
CHX occurs by inhibition of cell protein synthesis (20) 
and mitochondrial respiration (19), induction of apopto-
sis at low concentrations, and necrosis at elevated con-
centrations (19), this cytotoxic potential is related to the 
time of cell exposure and concentration of  CHX (8), but 
in the GICs this potential may be retarded by the slow 
release of CHX built into the cement network.
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Meron cement with CHX-18% demonstrated a dense 
granulation tissue and presence of multinucleated giant 
cells, with significant difference in comparison with 
the control (P=0.029) at 7 days, which corresponded 
to the body’s response in trying to isolate the foreign 
body (8,19), however, this condition did not persist in 
the other subsequent time intervals. This condition was 
less expressive than that found by other authors (5), who 
used CHX in a Chip in the subcutaneous tissue of rats, 
and experiments (5,21) that showed evidence of death of 
fibroblasts in culture after contact with CHX. This sug-
gests that GIC provided a slow and lower rate of CHX 
release than the total concentration used in the modifica-
tion of the cement formula.
The tissue exposed to Riva with CHX in higher con-
centrations presented a lower tissue repair capacity in 
the initial time intervals, since  Riva-CHX18% demons-
trated a lower quantity of fibroblasts (P=0.031) and co-
llagen (P=0.044) at 7 days, which is in alignment with 
studies that showed evidence of a reduction in the hea-
ling process (2,19) with a reduction in the production of 
non-collagenous protein  and collagen fibers (2). Howe-
ver, the quantities of young fibroblasts and collagen 
fibers increased during the course of the experimental 
time intervals (P>0.05).
The release of CHX on the GIC surface may have a rein-
forced antibacterial effect over the course of time, resul-
ting from superficial erosion, exposing a new surface for 
releasing CHX (6), which allows it to react with cellular 
structures and lead to direct cell damage or inhibition 
of bacterial cellular metabolism, due to its substantivity 
(4,19). On the whole, the addition of CHX to the ce-
ments demonstrated to be a highly promising method for 
obtaining of an antibacterial GIC for orthodontic cemen-
tation.
Conclusions
The antimicrobial effect was demonstrated to be concen-
tration-dependent. The addition of CHX did not nega-
Groups# N Meron Riva Luting P*
Mean (SD)
Control 10 0.37(0.17)a 0.23 (0.08)Ab 0.032
10% 10 0.47 (0.22) 0.41 (0.14)B 0.985
18% 10 0.49 (0.21) 0.56 (0.18)B 0.446
P* --- 0.385 0.001 ---
Table 3: Mean and standard deviation (SD) of the shear bond strength test values of 
the different groups, expressed in MPa. 
# Control (10% tartaric acid solution), 10% (addition of CHX at 10%), 18% (addition 
of CHX at 18%).
* Mean values followed by different letters, express statistically significant difference.
A,B (in columns, comparison between groups for the same GIC) according to ANOVA 
one-way and Tukey (P<0.05).
a,b (in lines, comparison between GIC) according to unpaired T test (P<0.05).
tively influence the SBST and ARI. Meron-CHX-10% 
was the most biocompatible, and Riva-CHX-18% had 
more influence on the inflammatory process and presen-
ted slower tissue repair. 
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